Summary
β2-Microglobulin (B2-MG) content was measured for the first time in the brain (caudate nucleus, putamen, and cerebral cortex) from control and parkinsonian patients by a highly sensitive sandwich enzyme immunoassay. The concentrations of B2-MG in dopaminergic striatal regions were significantly higher in parkinsonian patients than those in controls, whereas those in the cerebral cortex showed no significant difference between parkinsonian and control subjects. Tumor necrosis factor-α (TNF-α) concentrations were also increased in the striatum, confirming our previous findings, but not in the cerebral cortex. Since TNF-α may induce B2-MG expression, these results suggest that an immunological response may occur in the nigrostriatal dopaminergic regions in Parkinson's disease.
This is a preview of subscription content, access via your institution.
References
Aggarwal BB, Kohr WJ, Hass PE, Maffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985) Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 260: 2345–2354
Benveniste EN, Sparacio SM, Bethea JR (1989) Tumor necrosis factor-α enhances interferon-γ mediated class II antigen expression on astrocytes. J Neuroimmunol 25: 209–219
Beutler B, Cerami A (1988) Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57: 505–518
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 72: 248–254
Burakoff SJ, Engelhard VH, Kalfman J, Strominger JL (1980) Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens. Nature 283: 495–497
Chung IY, Benveniste EN (1990) Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1β. J Immunol 144: 2999–3007
Cresswell P, Springer T, Strominger JL, Turner MJ, Grey HM, Kubo RT (1974) Immunological identity of the small subunit of HL-A antigens and beta-2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 71: 2123–2127
Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 19: 689–694
Greenfield SA (1992) Cell death in Parkinson's disease. In: Tipton KF (ed) Essays in bochemistry, vol 27. Portland Press, London, pp 103–118
Grenier Y, Ruijs TC, Robitaille Y, Olivier A, Antel JP (1989) Immunohistochemical studies of adult human glial cells. J Neuroimmunol 21: 103–115
Herman A, Parham P, Weissman SM, Engelhard VH (1983) Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer. Proc Natl Acad Sci USA 80: 5056–5060
Hirayama M, Yokochi T, Shimokata K, Iida M, Fujiki N (1986) Induction of human leukocyte antigen-A,B,C and-DR on cultured human oligodendrocytes and astrocytes by human γ-interferon. Neurosci Lett 72: 369–374
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427–442
Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607–612
Klein J, Juretic A, Baxevanis CN, Nagy ZA (1981) The traditional and a new version of the mouse H-2 complex. Nature 291: 455–460
Mauerhoff T, Pujol-Borrell R, Mirakian R, Bottazzo GF (1988) Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain. J Neuroimmunol 18: 271–289
McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285–1291
Mogi M, Kojima K, Nagatsu T (1984) Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay. Anal Biochem 138: 125–132
Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T (1988) Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in Parkinsonian brain. J Neural Transm 72: 77–82
Mogi M, Harada M, Kojima K, Adachi T, Narabayashi H, Fujita K, Naoi M, Nagatsu T (1989) β2-Microglobulin decrease in cerebrospinal fluid from parkinsonian patients. Neurosci Lett 104: 241–246
Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208–210
Munoz-Fernandez MA, Armas-Portela R, Diaz-Nido J, Alonso JL, Fresno M, Avila J (1991) Differential effect of tumor necrosis factor on the growth and differentiation of neuroblastoma and glioma cells. Exp Cell Res 194: 161–164
Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346
Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF (1990) Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144: 129–135
Sternberg EM (1988) Monokines, lymphokines and brain. In: Cruse JM, Lewis RE (eds) The year in immunology 1988: immunoregulatory cytokines and cell growth. Karger, Basel, pp 205–217
Vitetta ES, Capra JD (1978) The protein products of the murine 17th chromosome: genetics and structure. Adv Immunol 26: 147–193
Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310: 688–691
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mogi, M., Harada, M., Kondo, T. et al. Brain β2-microglobulin levels are elevated in the striatum in Parkinson's diseaselevels are elevated in the striatum in Parkinson's disease. J Neural Transm Gen Sect 9, 87–92 (1995). https://doi.org/10.1007/BF02252965
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02252965
Keywords
- β2-Microglobulin
- tumor necrosis factor-α
- Parkinson's disease
- brain